Head-to-head · Value Score
bmiMD vs Remote Pharmacy
Two GLP-1 deals, scored on the same six factors. bmiMD lands a Value Score of 89, Remote Pharmacy a 77. Here's who gives you the honest lower price — and where each one bites back.
bmiMD
#11 · Grade A · Great Deal
Est. first month
$99/mo
Save ~93% vs brand-nameRemote Pharmacy
#109 · Grade B- · Fair Price
Est. first month
From $167/mo (all doses, compounded)
Save ~88% vs brand-nameThe verdict
bmiMD takes it on Value Score, 89 to 77 — an est. $99/mo first month, with no teaser step-up baked in. Remote Pharmacy isn't out of it: People who want low cash-pay compounded glp-1 with no subscription and free shipping.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | bmiMD | Remote Pharmacy |
|---|---|---|
| Value Score | 89 (A) | 77 (B-) |
| Est. first month | $99/mo | From $167/mo (all doses, compounded) |
| Save vs brand-name | ~93% | ~88% |
| Semaglutide | $99/mo | From $167/mo (all doses, compounded) |
| Tirzepatide | $139/mo | From $230/mo (all doses, compounded) |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Flat — no step-up |
| Coverage | All 50 states | Coverage not published |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
bmiMD
Sub-$100 semaglutide and a low $139 tirzepatide, flat and nationwide — a straight-up low-price play.
Why it's a deal
- $99 flat semaglutide and a low $139 tirzepatide
- Available in all 50 states
- Both molecules priced up front
The fine print
- Not LegitScript-certified — do your own pharmacy diligence
- Thin public track record; no oral or brand-name option
Remote Pharmacy
Remote Pharmacy is a US direct-to-consumer telehealth service offering compounded GLP-1 weight-loss medication on a cash-pay basis with no subscriptions or hidden fees.
Why it's a deal
- Low cash-pay pricing with no subscription or hidden fees
- Free doctor consultation and free shipping (you pay only for medication)
- Offers injectable and sublingual or tablet forms of both drugs
- Medication made by 503A-certified compounding facilities
The fine print
- Does not publicly name its specific compounding pharmacies or clinical provider
- Covered states are not listed on the pages reviewed
- Newer brand with limited third-party track record
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores bmiMD is ranked on the bmiMD alternatives board, and the same list for the other side is on alternatives to Remote Pharmacy.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.